COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

29,934 Articles (22,057 medRxiv, 7,877 bioRxiv)

Most recent first Previous |  Page 2723: Articles 27221-27230  | Next

Population vulnerability to COVID-19 in Europe: a burden of disease analysis
Wyper, G. M., Assuncao, R. M., Cuschieri, S., Devleeschauwer, B., Fletcher, E., Haagsma, J. A., Hilderink, H., Idavain, J., Lesnik, T., Von der Lippe, E., Majdan, M., Milicevic, M. S., Pallari, E., Penalvo, J. L., Pires, S. M., Plass, D., Santos, J. V., Thomsen, S. T., Stockton, D. L., Grant, I.
10.1101/2020.04.29.20064279 — Posted: 2020-05-04 Discussion: Offsite
Balancing revenue generation with capacity generation: Case distribution, financial impact and hospital capacity changes from cancelling or resuming elective surgeries in the US during COVID-19
TONNA, J. E., Hanson, H. A., Cohan, J. N., McCrum, M. L., Horns, J. J., Brooke, B. S., Das, R., Kelly, B. C., Campbell, A. J., Hotaling, J.
10.1101/2020.04.29.20066506 — Posted: 2020-05-04
Predicted impact of the COVID-19 pandemic on global tuberculosis deaths in 2020
Glaziou, P.
10.1101/2020.04.28.20079582 — Posted: 2020-05-04
AKI during COVID-19 infection: low incidence, high risk of death
Mou, Z., Zhang, X.
10.1101/2020.04.29.20079038 — Posted: 2020-05-04
Negative impact of hyperglycemia on Tocilizumab therapy in COVID-19 patients
Marfella, R., Paolisso, P., Sardu, C., Bergamaschi, L., D' Angelo, E. C., Barbieri, M., Rizzo, M. R., Messina, V., Maggi, P., Coppola, N., Pizzi, C., Biffi, M., Viale, P. L., Galie, N., Paolisso, G.
10.1101/2020.04.29.20076570 — Posted: 2020-05-04
Sensitivity assessment of SARS-CoV-2 PCR assays developed by WHO referral laboratories
Etievant, S., Bal, A., Escurret, V., Brengel-Pesce, K., Bouscambert, M., Cheynet, V., Generenaz, L., Oriol, G., Destras, G., Billaud, G., Josset, L., Frobert, E., Morfin, F., Gaymard, A.
10.1101/2020.05.03.20072207 — Posted: 2020-05-04
A simulation-based procedure to estimate base rates from Covid-19 antibody test results I: Deterministic test reliabilities
Joosten, R., Abhishta, A.
10.1101/2020.04.28.20075036 — Posted: 2020-05-04
Commercial stocks of SARS-CoV-2 RNA may report low concentration values, leading to artificially increased apparent sensitivity of diagnostic assays
Jue, E., Ismagilov, R. F.
10.1101/2020.04.28.20077602 — Posted: 2020-05-04
Detection of SARS-CoV-2 in Human Breast Milk
Gross, R., Conzelmann, C., Müller, J., Stenger, S., Steinhart, K., Kirchhoff, F., Münch, J.
10.1101/2020.04.28.20075523 — Posted: 2020-05-04 Discussion: Onsite
Evaluation of Turkish social distancing measures on the spread of COVID-19
civcir, i.
10.1101/2020.04.28.20083550 — Posted: 2020-05-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).